Chemoinformaics analysis of CYANIDIN-3-SAMBUBIOSIDE
| Molecular Weight | 616.956 | nRot | 6 |
| Heavy Atom Molecular Weight | 587.724 | nRig | 29 |
| Exact Molecular Weight | 616.12 | nRing | 5 |
| Solubility: LogS | -2.709 | nHRing | 3 |
| Solubility: LogP | -0.726 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
| nHA | 14 | APOL | 76.967 |
| nHD | 10 | BPOL | 37.773 |
| QED | 0.122 |
| Synth | 4.912 |
| Natural Product Likeliness | 2.169 |
| NR-PPAR-gamma | 0.935 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.941 |
| HIA | 0.969 |
| CACO-2 | -6.426 |
| MDCK | 0.0000313 |
| BBB | 0.312 |
| PPB | 0.830299 |
| VDSS | 0.712 |
| FU | 0.25203 |
| CYP1A2-inh | 0.015 |
| CYP1A2-sub | 0.018 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.096 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.003 |
| CL | 1.458 |
| T12 | 0.643 |
| hERG | 0.008 |
| Ames | 0.635 |
| ROA | 0.062 |
| SkinSen | 0.046 |
| Carcinogencity | 0.116 |
| EI | 0.014 |
| Respiratory | 0.017 |
| NR-Aromatase | 0.934 |
| Antiviral | Yes |
| Prediction | 0.558753 |